Treatment outcomes for various cancer indications certainly benefit from both early detection and the selection of the most appropriate targeted therapeutics, which are often guided in their use by companion diagnostic tests. In this second part of our series on bladder cancer we review how the new evolving ecosystem of precision medicine is playing a significant role in the research and development of new treatments for this condition.